Log in to save to my catalogue

Methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tum...

Methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tum...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_211959529

Methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis

About this item

Full title

Methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis

Publisher

Northfield: College of American Pathologists

Journal title

Archives of pathology & laboratory medicine (1976), 2007-10, Vol.131 (10), p.1555

Language

English

Formats

Publication information

Publisher

Northfield: College of American Pathologists

More information

Scope and Contents

Contents

* Context.--[alpha]-Methylacyl CoA racemase (AMACR) is an oxidative enzyme involved in isomeric transformation of fatty acids entering the beta-oxidation pathway. AMACR serves as a useful marker in establishing a diagnosis of prostatic malignancy; however, limited information is available in regard to its presence in pulmonary neoplasms. Objective....

Alternative Titles

Full title

Methylacyl CoA racemase in pulmonary adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors: expression and survival analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_211959529

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_211959529

Other Identifiers

ISSN

1543-2165,0003-9985

E-ISSN

1543-2165

How to access this item